James E. Dahlman

12.8k citations
76 papers · 7.3k · 7 hit papers · h-index 40

Impact in

  • Biomaterials top 0.5%
    • Nanoparticle-Based Drug Delivery
    • RNA Interference and Gene Delivery
    • Advanced biosensing and bioanalysis techniques
    • CRISPR and Genetic Engineering

Papers in

    • RNA Interference and Gene Delivery 51
    • Advanced biosensing and bioanalysis techniques 25
    • CRISPR and Genetic Engineering 12
    • Lipid Membrane Structure and Behavior 8
    • MicroRNA in disease regulation 11

James E. Dahlman

74 papers receiving 7.1k citations

James E. Dahlman's Hit Papers

Drug delivery systems for CRISPR-based genome editors 2023 · 98 citations
980+5+10Years since publication250500750

Peers

James E. Dahlman
Comparison fields: 5 of 157
  • Biomaterials 1.4k
  • Molecular Biology 5.0k
  • Cancer Research 694
  • Immunology 795
  • Pharmaceutical Science 224
Replace Qiang Cheng with:
Qiang Cheng China
Roy van der Meel Netherlands
Tuo Wei China
Gaurav Sahay United States
Jayesh A. Kulkarni Canada
Dominik Witzigmann Canada
Enrico Mastrobattista Netherlands
Shubiao Zhang China
Qiang Feng China
Margaret M. Billingsley United States
James E. Dahlman relative to Qiang Cheng China Qiang Cheng's profile →
Citations per field
00.5×1.5×1.9×
Qiang Cheng · 1×
Citations per year

Countries citing papers authored by James E. Dahlman

Since Specialization
Citations

This map shows the geographic impact of James E. Dahlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dahlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dahlman more than expected).

Fields of papers citing papers by James E. Dahlman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Dahlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dahlman. The network helps show where James E. Dahlman may publish in the future.

Co-authors

The 25 scholars most cited alongside James E. Dahlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James E. Dahlman Line = papers co-authored together James E. Dahlman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Treating metastatic cancer with nanotechnology
Hit paper breakdown →
2011952
2
Drug delivery systems for RNA therapeutics
Hit paper breakdown →
2022867
3
Emerging Frontiers in Drug Delivery
Hit paper breakdown →
2016781
4
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs
Hit paper breakdown →
2021357
5
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure
Hit paper breakdown →
2016328
6 2018252
7 2017250
8 2014204
9 2015198
10 2018193
11 2019167
12 2011146
13 2021132
14
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo
Hit paper breakdown →
2022130
15 2018130
16 2015129
17 2019126
18 2018108
19 2015104
20
Drug delivery systems for CRISPR-based genome editors
Hit paper breakdown →
202398

About James E. Dahlman

James E. Dahlman is a scholar working on Molecular Biology, Cancer Research, Immunology, Genetics and Infectious Diseases, having authored 76 papers that have together received 7.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (25 papers), CRISPR and Genetic Engineering (12 papers), MicroRNA in disease regulation (11 papers), Lipid Membrane Structure and Behavior (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Virus-based gene therapy research (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Biomaterials (1.4k citations), Molecular Biology (5.0k citations), Cancer Research (694 citations), Immunology (795 citations) and Pharmaceutical Science (224 citations). James E. Dahlman has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Róbert Langer, Kalina Paunovska, David Loughrey, Mark W. Tibbitt, Daniel G. Anderson, Melissa P. Lokugamage, Cory D. Sago, Tyler Jacks, Avi Schroeder and Monte M. Winslow. Their work appears in journals such as Nano Letters, Proceedings of the National Academy of Sciences, Advanced Materials, Nature Communications and Nature Nanotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact